Life Sciences, Drugs, Executives

Molecular Insight Names CEO, Chair

Ryan McBride 2/3/09

Molecular Insight Pharmaceuticals (NASDAQ:MIPI), based in Cambridge, MA, says that its board of directors has made John Babich its CEO and Anthony Martin its non-executive chairman of the board, among other leadership changes. Babich had served as interim chairman and CEO since September 2008, when the board of directors decided to replace former CEO David Barlow, whose resignation from the board was announced last month.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.